What Are Toxin-Mediated Diseases?
Discussion A poison is a generic term for “a substance with an inherent property that tends to destroy life or impair health.” A toxin is more specific and is “any poison produced by an organism, characterized by antigenicity in certain animals and high molecular weight, and including the bacterial toxins that are the causative agents of tetanus, diphtheria, etc., and such plant and animal toxins as ricin and snake venom.” A toxin does not include those substances that are made synthetically produced. Venom is also a toxin that is used by animals and insects for predation or defense which can cause ...
Source: PediatricEducation.org - April 12, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19, Frontiers in immunology
Sepsis is a life-threatening systemic illness attributed to a dysregulated host response to infection. Sepsis is a global burden killing ~11 million persons annually. In December 2019, a novel pneumonia condition termed coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged and has resulted in more than 1,535,982 deaths globally as of 8 th December 2020. These two conditions share many pathophysiological and clinical features. Notably, both sepsis and COVID-19 patients experience consumptive thrombocytopenia, haemolytic anaemia, vascular microthrombosis, multi-o...
Source: Current Awareness Service for Health (CASH) - April 9, 2021 Category: Consumer Health News Source Type: news

COVID-19: it's all about sepsis, Future microbiology
Initially considered as a community-acquired pneumonia that could worsen into the acute respiratory distress syndrome, it soon became apparent that dysfunction of other organs, in addition to the lungs, is often present in patients with COVID-19; indeed, multiple organ failure (MOF) accounts for most of the deaths from COVID19 [3]. MOF in COVID-19 can involve any organs, the six most common being the lungs, the cardiovascular system, the kidneys, the brain, the liver and the coagulation system. COVID-19 is characterized by a thrombotic endotheliopathy involving the entire body. The resulting endothelial dysfunction may be ...
Source: Current Awareness Service for Health (CASH) - April 9, 2021 Category: Consumer Health News Source Type: news

Africa: Social Media Users in Kenya and South Africa Trust Science, but Still Share Covid-19 Hoaxes
[The Conversation Africa] The COVID-19 pandemic has led to widespread disinformation circulating on social media globally. This includes false information about the virus, its origins and possible cures for the disease it causes. Much of the inaccurate information was related to China, the country where the first cases of an atypical pneumonia were reported in December 2019. This was determined in January 2020 to be caused by a novel coronavirus. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 7, 2021 Category: African Health Source Type: news

Mortality, Readmission Low With COVID-19 Discharge on Home Oxygen
FRIDAY, April 2, 2021 -- For patients with COVID-19 pneumonia, rates of mortality and 30-day readmission are low with discharge on home oxygen, according to a study published online April 1 in JAMA Network Open. Josh Banerjee, M.D., M.P.H., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 2, 2021 Category: Pharmaceuticals Source Type: news

Peter Jones health: Dragons' Den star recalls terrifying battle with pneumonia - symptoms
PETER JONES, 55, is best known for delivering hard reality checks to would-be entrepreneur's on BBC Two's Dragons' Den. The business tycoon was dealt a sobering lesson of his own when he contracted pneumonia in 2010. (Source: Daily Express - Health)
Source: Daily Express - Health - April 1, 2021 Category: Consumer Health News Source Type: news

Outcomes of patients with COVID-19 after discharged with supplemental home oxygen
(JAMA Network) This observational study examined death and hospital readmission rates of patients with COVID-19 pneumonia after being discharged to home or quarantine housing with supplemental home oxygen. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 1, 2021 Category: Infectious Diseases Source Type: news

The U.S. Death Rate Rose Significantly During the COVID-19 Pandemic
COVID-19 was the third-most-common cause of death in the U.S. in 2020, contributing to more than 375,000 deaths, and a 16% increase in the national death rate, according to provisional data published today by the U.S. Centers for Disease Control and Prevention (CDC). All told, more than 3.3 million people in the U.S. died in 2020, for a rate of about 829 deaths per 100,000 people. That’s up from about 715 deaths per 100,000 people in 2019. ( function() { var func = function() { var iframe = document.getElementById('wpcom-iframe-cc2cb8dfd195b43a5d43643e9ec19ffa') if ( iframe ) { iframe.onload =...
Source: TIME: Health - March 31, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

Thoracic radiologists give top tips for CT evaluation of lung parenchyma
What do the specialists say when it comes to the notoriously tricky area o...Read more on AuntMinnie.comRelated Reading: CT plus deep learning distinguishes COVID-19 from other pneumonia CT shows lung damage 6 months after COVID-19 recovery CT radiomics classifies small nodules found in CT lung screening Lung involvement portends COVID-19 mortality risk CTPA shows promise as a PE predictor in COPD patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 30, 2021 Category: Radiology Source Type: news

Lawmakers: Require nursing homes to disclose vaccine data
Nursing homes have to publicly disclose their vaccination rates for flu and pneumonia, but there’s no similar mandate for COVID-19 shots (Source: ABC News: Health)
Source: ABC News: Health - March 25, 2021 Category: Consumer Health News Tags: Health Source Type: news

Lessons From COVID-19 Can Improve Pneumonia Management Lessons From COVID-19 Can Improve Pneumonia Management
What have we learned from the current COVID-19 pandemic that can apply to the management of pneumonia?Current Opinion in Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 24, 2021 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Pneumonia in Kids: Amoxicillin vs Cephalosporins Pneumonia in Kids: Amoxicillin vs Cephalosporins
The Cribsiders offer their favorite tips on diagnosing and treating childhood CAP.The Cribsiders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 22, 2021 Category: Consumer Health News Tags: Pediatrics Commentary Source Type: news

RedHill announces compassionate use treatment with opaganib of Swiss COVID-19 patients
(RedHill Biopharma) RedHill Biopharma Ltd. (Nasdaq: RDHL) today announced that it has acted on a request to provide opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffering from COVID-19 pneumonia. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 22, 2021 Category: Infectious Diseases Source Type: news

Amid COVID, potentially avoidable hospitalizations for other conditions fell far more for whites than Blacks
During the first six months of the pandemic, as people attempted to stay away from hospitals caring for those sick with COVID-19, potentially avoidable hospitalizations for non-COVID-19 –related conditions fell far more among white patients than Black patients, according to a new study that looked at admissions to UCLA Health hospitals.The findings indicate that the COVID-19 crisis has exacerbated existing racial health care disparities and suggest that during the pandemic, African Americans may have had worse access than whites to outpatient care that could have helped prevent deterioration of their non –COVID...
Source: UCLA Newsroom: Health Sciences - March 19, 2021 Category: Universities & Medical Training Source Type: news

Early Tracheotomy Tied to Less Pneumonia, Fewer Ventilator Days, Shorter ICU Stays Early Tracheotomy Tied to Less Pneumonia, Fewer Ventilator Days, Shorter ICU Stays
Early tracheotomy placement in critically ill patients is associated with lower ventilator-associated pneumonia rates, but not with reduced short-term mortality compared to late placement, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 18, 2021 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

'Frankenstein' datasets, other flaws hamper COVID-19 AI studies
Promising results were reported in 2020 for many artificial intelligence (AI)-base...Read more on AuntMinnie.comRelated Reading: CT plus deep learning distinguishes COVID-19 from other pneumonia AI training sets often aren't geographically diverse SIIM 2020: Human element shouldn't be neglected with AI Could imaging AI research be endangering patients? AI needs robust clinical evaluation in healthcare (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 18, 2021 Category: Radiology Source Type: news

Lung ultrasound spots COVID-19 in newborns
For neonates suspected of having COVID-19 pneumonia, what's the best way t...Read more on AuntMinnie.comRelated Reading: Lung ultrasound at bedside predicts COVID-19 outcomes Ultrasound outperforms x-ray for neonatal pneumothorax Take caution when analyzing pediatric brain development Imaging confirms coronavirus transmits from mother to fetus CT details effect of COVID-19 on pregnant women (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 18, 2021 Category: Radiology Source Type: news

Rates of Macrolide Resistance in S. pneumoniae High Across the U.S.
Clinicians should consider alternatives to macrolide monotherapy as empiric therapy for suspected community - acquired bacterial pneumonia (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 17, 2021 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news

Effect of vancomycin loading dose on clinical outcome in critically ill patients with methicillin-resistant Staphylococcus aureus pneumonia, Journal of Thoracic Disease 13(2): 768-777
Background: Vancomycin is the treatment of choice for serious methicillin-resistant Staphylococcus aureus (MRSA) infections. Current guidelines recommend giving an initial loading dose (LD) of 25-30 mg/kg to rapidly increase the serum concentration. However, high-quality evidence for the clinical benefit of LD is lacking. Herein, we aim to examine the association between vancomycin LD and clinical outcome. Methods: A retrospective cohort study was conducted on adult patients treated for MRSA pneumonia with vancomycin in medical intensive care units from April 2016 to August 2018. MRSA pneumonia was defined by the Centers f...
Source: Current Awareness Service for Health (CASH) - March 17, 2021 Category: Consumer Health News Source Type: news

CT results in COVID-19 patients predict abnormal brain MRI findings
CT images of severe COVID-19 may help clinicians predict patients' vulnerabilit...Read more on AuntMinnie.comRelated Reading: Adenopathy may occur after COVID-19 vaccination Consider COVID-19 chest imaging patterns to prep for next pandemic Heart disease rare in pro athletes after COVID-19 CT plus deep learning distinguishes COVID-19 from other pneumonia Can AI predict COVID-19 hot spots from chest CT reports? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 15, 2021 Category: Radiology Source Type: news

'The story is .. still being written': A pandemic Q&A with Health Minister Patty Hajdu
Health Minister Patty Hajdu was away on holiday with her partner at the start of January 2020 when he brought to her attention a strange report out of China about an unexplained pneumonia. (Source: CBC | Health)
Source: CBC | Health - March 13, 2021 Category: Consumer Health News Tags: News/Politics Source Type: news

Online COVID-19 Symptom Checkers May Not Catch Severe Illnesses Online COVID-19 Symptom Checkers May Not Catch Severe Illnesses
Digital COVID-19 symptom checkers in the US and the UK may fail to identify severe COVID-19 and other serious illnesses such as bacterial pneumonia or sepsis, according to a group of public health researchers.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - March 12, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

AI algorithm could aid radiologists in evaluating chest CT exams
Artificial intelligence (AI) software could be a valuable tool for radiologist...Read more on AuntMinnie.comRelated Reading: Top 10 questions to ask when buying radiology AI software Will radiologists need to buy AI themselves to drive adoption? CT plus deep learning distinguishes COVID-19 from other pneumonia AI can help radiologists find, classify rib fractures on CT Can AI predict COVID-19 hot spots from chest CT reports? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 12, 2021 Category: Radiology Source Type: news

Roche Says Actemra-Remdesivir Trial Fails to Cut Hospital Stays Roche Says Actemra-Remdesivir Trial Fails to Cut Hospital Stays
Swiss drugmaker Roche said on Thursday adding its drug Actemra to Gilead Sciences'Veklury medication, also called remdesivir, did not reduce hospital stays for patients with severe COVID-19 pneumonia.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - March 12, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Combo of Genentech, Gilead drugs fails Covid trial
The study is one of three late-stage clinical trials that Genentech has undertaken to assess the use of the rheumatoid arthritis drug Actemra in Covid patients with pneumonia. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 11, 2021 Category: American Health Authors: Ron Leuty Source Type: news

Combo of Genentech, Gilead drugs fails Covid trial
The study is one of three late-stage clinical trials that Genentech has undertaken to assess the use of the rheumatoid arthritis drug Actemra in Covid patients with pneumonia. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 11, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Roche provides update on the phase III REMDACTA trial of Actemra/RoActemra plus Veklury in patients with severe COVID-19 pneumonia
Basel, 11 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the global phase III randomised, double-blind, multicentre REMDACTA study of Actemra ®/RoActemra® (tocilizumab) plus Veklury® (remdesivir), versus placebo plus Veklury, did not meet its primary endpoint. This was measured by improved time to hospital discharge up to day 28 in patients with severe COVID-19 pneumonia receiving standard of care. No new safety signals were identified for Actemra/RoActemra in the REMDACTA trial. The study was conducted in collaboration with Gilead Sciences, Inc. (Source: Roche Media News)
Source: Roche Media News - March 11, 2021 Category: Pharmaceuticals Source Type: news

Roche provides update on the phase III REMDACTA trial of Actemra/RoActemra plus Veklury in patients with severe COVID-19 pneumonia
Basel, 11 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the global phase III randomised, double-blind, multicentre REMDACTA study of Actemra ®/RoActemra® (tocilizumab) plus Veklury® (remdesivir), versus placebo plus Veklury, did not meet its primary endpoint. This was measured by improved time to hospital discharge up to day 28 in patients with severe COVID-19 pneumonia receiving standard of care. No new safety signals were identified for Actemra/RoActemra in the REMDACTA trial. The study was conducted in collaboration with Gilead Sciences, Inc. (Source: Roche Investor Update)
Source: Roche Investor Update - March 11, 2021 Category: Pharmaceuticals Source Type: news

Early tracheotomy helps patients avoid ventilator-associated pneumonia, team finds
(University of Texas Health Science Center at San Antonio) Tracheotomy, a surgical procedure to open the windpipe, reduces risk of ventilator-associated pneumonia, a new review of 17 published studies reveals. Authors include faculty from the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 11, 2021 Category: International Medicine & Public Health Source Type: news

Short-Course Antibiotics Noninferior for Pediatric Pneumonia
WEDNESDAY, March 10, 2021 -- Five days of antibiotic therapy is noninferior to standard care for treatment of children with community-acquired pneumonia (CAP), according to a study published online March 8 in JAMA Pediatrics. Jeffrey M. Pernica,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 10, 2021 Category: Pharmaceuticals Source Type: news

Five days of antibiotics fine for children with pneumonia
(McMaster University) The study, involving 281 Ontario children, found that 85.7% of those who received the short course of antibiotics and 84.1% of those who received the longer course of medication were cured two to three weeks later. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 8, 2021 Category: International Medicine & Public Health Source Type: news

I Avoided Facing My Mental Illness for Decades. The Pandemic Changed That
“I didn’t leave my apartment for days, weeks. Time became meaningless.”“I was struggling with almost every aspect of my life.”ide class="right-rail__container right-rail__container--ad"> Several years ago, when I was in my mid-20s, after suffering from major depressive disorder and anxiety for most of my life, I found myself at the emergency room during an episode of substance-induced psychosis. My father and stepmother found me, at the very beginning of the episode, having paranoid delusions. Someone had tried to poison me and now they were coming, I told them. “Do not ans...
Source: TIME: Health - March 3, 2021 Category: Consumer Health News Authors: Jaquira Díaz Tags: Uncategorized COVID-19 feature health Magazine Women in Crisis Source Type: news

Study unravels antibiotic resistance in MRSA ‘superbug’ infections
FINDINGSResearchers applied a new approach pioneered at UCLA to predict whichmethicillin-resistant Staphylococcus aureus, or MRSA,infections willfail to respond toantibiotic treatment. By focusing on epigenetics — changes to gene expression that can’t be detected by standard DNA sequencing — the study examined how the immune system recognizes dangerous superbugs and works with antibiotics to clear them.BACKGROUNDThe Staphylococcus aureus bacterium can  live harmlessly on a person’s skin and in their nose, occasionally causing mild infections that can be treated with standard antibiotics. When i...
Source: UCLA Newsroom: Health Sciences - March 3, 2021 Category: Universities & Medical Training Source Type: news

CT plus deep learning distinguishes COVID-19 from other pneumonia
A deep-learning algorithm improves CT's capability for distinguishing betwee...Read more on AuntMinnie.comRelated Reading: Can AI predict COVID-19 hot spots from chest CT reports? COVID-19 vaccine affects imaging results, researchers warn AI can predict need for steroid treatments in COVID-19 patients CT quantifies COVID-19 severity, ongoing conditions COVID-19, AI, and dose reduction top RSNA's CT agenda (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 3, 2021 Category: Radiology Source Type: news

Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia, Inflammation research, 70(2): 159-170
Conclusions: The present state of art in the use of individual MNs in acute disorders suggests planning adjuvant therapy trials utilizing MN combinations aimed at counteracting proinflammatory conditions, as in the case of pneumonia and the COVID-19 pandemic. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 3, 2021 Category: Consumer Health News Source Type: news

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia, New England Journal of Medicine
This placebo-controlled Phase III study of tocilizumab in patients hospitalised with severe Covid-19 pneumonia found no improvement in clinical status (primary endpoint; between-group difference -1.0; 95% CI -2.5 to 0; p=0.31) or mortality (19.7% v 19.4%; p=0.94) at day 28. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 1, 2021 Category: Consumer Health News Source Type: news

Repurposed arthritis drug did not significantly improve severe COVID-19 pneumonia
(University of California - San Diego) A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 1, 2021 Category: Infectious Diseases Source Type: news

Integrated community case management of childhood pneumonia in Nigeria highly cost effective
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - March 1, 2021 Category: Drugs & Pharmacology Source Type: news

GSK Will Focus on Elderly in Trial to Treat Pneumonia From COVID GSK Will Focus on Elderly in Trial to Treat Pneumonia From COVID
GlaxoSmithKline will extend a trial testing an experimental rheumatoid arthritis drug on patients suffering from COVID-related pneumonia in order to focus on the elderly.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - February 26, 2021 Category: Orthopaedics Tags: Pulmonary Medicine News Source Type: news

Roche receives positive CHMP opinion for Evrysdi, the first and only at home spinal muscular atrophy (SMA) treatment with proven efficacy in adults, children and infants two months and older
Basel, 26 February 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Evrysdi ™ (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients 2 months of age and older, with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies. SMA is a leading genetic cause of death in infants and 5q SMA is the most common form of the disease . SMA causes progressive muscle weakness and atrophy, and significant unmet need remains, particularly in adults ...
Source: Roche Media News - February 26, 2021 Category: Pharmaceuticals Source Type: news

Roche receives positive CHMP opinion for Evrysdi, the first and only at home spinal muscular atrophy (SMA) treatment with proven efficacy in adults, children and infants two months and older
Basel, 26 February 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Evrysdi ™ (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients 2 months of age and older, with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies. SMA is a leading genetic cause of death in infants and 5q SMA is the most common form of the disease . SMA causes progressive muscle weakness and atrophy, and significant unmet need remains, particularly in adults ...
Source: Roche Investor Update - February 26, 2021 Category: Pharmaceuticals Source Type: news

Ventilator-Associated Pneumonia in COVID-19 Patients Ventilator-Associated Pneumonia in COVID-19 Patients
How often does ventilator-associated pneumonia develop in COVID-19 patients, and what factors may increase the risk?Critical Care (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - February 25, 2021 Category: Intensive Care Tags: Critical Care Journal Article Source Type: news

SOFA Score Not Helpful for Ventilator Triage in Patients With COVID-19 Pneumonia SOFA Score Not Helpful for Ventilator Triage in Patients With COVID-19 Pneumonia
The Sequential Organ Failure Assessment (SOFA) score has'inadequate'discriminant accuracy for ventilator triage of patients with COVID-19, clinicians caution.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - February 25, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Ridges on toenails: How to get rid of them - what do they mean?
RIDGES on toenails can be painful and unpleasant, and they may be caused by a condition known as Beau's lines. This is how to get rid of toenail ridges, and what may be causing them, including diabetes, vitamin deficiency, and even pneumonia. (Source: Daily Express - Health)
Source: Daily Express - Health - February 23, 2021 Category: Consumer Health News Source Type: news

Lost your appetite? Experts say nutmeg oil can bring it back
(Natural News) Loss of appetite is a common symptom that can be caused by a wide variety of conditions. For instance, bacterial, fungal and viral infections, such as upper respiratory tract infections, skin infections, pneumonia or gastroenteritis, can all cause loss of appetite. Stress, boredom, anxiety and depression are also known to cause this symptom. Other... (Source: NaturalNews.com)
Source: NaturalNews.com - February 19, 2021 Category: Consumer Health News Source Type: news

UK Interim Clinical Commissioning Policy for tocilizumab has been updated to cover a wider group of hospitalised COVID-19 positive patients, DHSC
NHS trusts/health boards are recommended to consider prescribing single dose of tocilizumab to eligible hospitalised patients with COVID-19 pneumonia, typically as adjuvant treatment to dexamethasone as standard of care, following announcement of findings of RECOVERY trial. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 19, 2021 Category: Consumer Health News Source Type: news

Clinical course of SARS-CoV-2 infection in patients with severe acquired brain injury and a disorder of consciousness: an observational study - Caronni A, Liaci E, Bianchi A, Vigan ò A, Marenco F, Comanducci A, Cabrini DM, Meloni M, Alberoni M, Farina E, Bianco M, Galeri S, Devalle G, Navarro J.
PURPOSE: SARS-CoV-2 infection can cause the coronavirus disease (COVID), ranging from flu-like symptoms to interstitial pneumonia. Mortality is high in COVID pneumonia and it is the highest among the frailest. COVID could be particularly serious in patient... (Source: SafetyLit)
Source: SafetyLit - February 17, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

COVID-19 rapid guideline: critical care in adults [NG159], NICE (updated 12th February 2021)
Updated On 12 February 2021, we added advice to follow NHS England's interim clinical commissioning policies on tocilizumab and sarilumab for treating critically ill patients with COVID-19 pneumonia. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 12, 2021 Category: Consumer Health News Source Type: news

RUDN University veterinarians tested a new drug against pneumonia in calves
(RUDN University) Respiratory tract diseases in young animals of the cattle are a big issue for world agriculture and food safety because a bacterium that causes them is resistant to most antibiotics. A team of veterinarians from RUDN University developed and tested a complex preparation called gentaminoseleferon that could help treat respiratory infection in calves. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 10, 2021 Category: Biology Source Type: news

COVID-19 Vaccination information for health care professionals, BTS
This document provides information for respiratory health care professionals in relation to the current COVID-19 vaccination programme and covers issues that may arise in discussion with patients. This might include questions around safety or immune responses from patients with chronic respiratory disease, or on immunosuppression for lung conditions as well as more general questions around vaccines/immunisation programme, including Influenza, and pneumococcal vaccines. We also highlight the role of respiratory healthcare professionals as advocates for vaccination. A significant constituency of patients may be fearful or ...
Source: Current Awareness Service for Health (CASH) - February 4, 2021 Category: Consumer Health News Source Type: news